A thyroglobulin test is a blood test that measures the level of thyroglobulin, a protein produced exclusively by thyroid cells. Its primary use is monitoring for cancer recurrence in people who have had their thyroid gland surgically removed due to differentiated thyroid cancer (the most common type). In people with an intact thyroid, it can also help evaluate certain thyroid conditions, though this is less common.
What Thyroglobulin Actually Does
Thyroglobulin is a large protein made by the cells lining your thyroid gland. It serves two critical jobs: storing iodine and acting as the scaffold your body uses to build thyroid hormones. To make the main thyroid hormone (T4), your thyroid first attaches iodine to specific spots on thyroglobulin, then combines two of those iodinated building blocks together while they’re still part of the protein. Think of thyroglobulin as both a warehouse and a workbench for thyroid hormone production.
Because only thyroid cells produce thyroglobulin, the protein works as a highly specific marker. If your thyroid has been completely removed, thyroglobulin levels should drop to near zero. Any measurable amount after that point signals that thyroid tissue still exists somewhere in the body, whether residual normal tissue or cancer cells.
Why the Test Is Ordered
The most common reason is long-term surveillance after thyroid cancer treatment. After a thyroidectomy (surgical removal of the thyroid), and often a follow-up round of radioactive iodine to destroy any remaining thyroid tissue, thyroglobulin becomes a tumor marker. Rising levels suggest cancer may have returned or spread. Falling levels suggest any remaining disease is receding.
Guidelines recommend measuring thyroglobulin every 3 to 6 months for the first 2 years after surgery, then every 6 to 12 months beyond that. It’s typically used alongside neck ultrasounds and, in some cases, radioactive scans to build a complete picture of whether the cancer has come back.
Less commonly, the test is ordered in people who still have their thyroid. In that setting, it can help evaluate unexplained thyroid enlargement or distinguish between different types of thyroid inflammation. However, an elevated level in someone with an intact thyroid doesn’t point to cancer on its own, since many benign conditions raise thyroglobulin.
Normal Ranges and What Results Mean
For someone with an intact thyroid gland, levels up to 33 ng/mL are considered within the normal reference range. This applies across all ages.
For someone who has had a total thyroidectomy, the target is very different. Thyroglobulin should be undetectable or extremely low. The exact cutoff depends on the sensitivity of the lab’s testing method, but generally anything below 0.1 to 0.5 ng/mL (depending on the assay) is considered a reassuring result. The trend over time matters more than any single number. A thyroglobulin level that was undetectable and then becomes measurable, or one that steadily climbs from one test to the next, is a red flag that prompts closer investigation.
Elevated Levels Without Cancer
A high thyroglobulin level doesn’t automatically mean cancer. In people with an intact thyroid, levels can be markedly elevated with benign thyroid nodules, Graves’ disease, Hashimoto’s thyroiditis, goiter, or other inflammatory thyroid conditions. Research has shown that benign nodules alone can push thyroglobulin high enough to mislead physicians into suspecting malignancy. This is one reason the test is most useful in the post-surgery monitoring context, where there’s a clear baseline (near zero) to compare against.
Stimulated vs. Unstimulated Testing
Thyroid-stimulating hormone (TSH) directly influences how much thyroglobulin thyroid cells release. A higher TSH level coaxes more thyroglobulin out of any remaining thyroid tissue, making small amounts of residual or recurrent cancer easier to detect. This is the basis for two different approaches to the test.
An unstimulated test is drawn while you’re taking your normal thyroid hormone replacement medication, which keeps TSH low. It’s convenient and avoids side effects, but it can miss low-level disease. In one study of post-surgical thyroid cancer patients, about 25% of those with a low unstimulated thyroglobulin turned out to have significantly elevated levels once TSH was raised. Those patients would have been falsely reassured of a disease-free status based on the unstimulated test alone.
A stimulated test raises TSH in one of two ways. The traditional method requires you to stop taking thyroid hormone replacement for about four weeks, allowing TSH to climb above 30 µIU/mL. The downside is real: most patients experience weight gain, fatigue, swelling, and other hypothyroid symptoms that can significantly affect quality of life during that month. The alternative is an injection of synthetic TSH (recombinant human TSH), which achieves the same stimulation without the hypothyroid symptoms, though it’s expensive and not available at all centers. Stimulated testing is considered more sensitive and reliable for detecting recurrence.
The Antibody Problem
About 20 to 25% of thyroid cancer patients produce thyroglobulin antibodies, proteins that bind to thyroglobulin in the blood. These antibodies create a significant testing challenge. In standard immunoassay testing (the most common lab method), thyroglobulin antibodies block the test’s ability to detect thyroglobulin, producing falsely low or even undetectable results. This means a patient could have active cancer producing thyroglobulin, yet the test reads as zero.
This is why labs almost always run a thyroglobulin antibody test alongside the thyroglobulin test itself. If antibodies are present, the thyroglobulin number can’t be fully trusted. In that situation, some clinicians track the antibody levels themselves as an indirect marker: rising antibody levels in a patient with no thyroid gland can signal recurrence, even when thyroglobulin appears undetectable.
Research also suggests that thyroglobulin antibodies don’t just interfere with the lab test. They may actually clear thyroglobulin from the bloodstream in the body itself, reducing the real circulating levels before the blood even reaches the test tube. This makes the interference biological as well as analytical.
Testing Methods: Immunoassay vs. Mass Spectrometry
Most labs measure thyroglobulin using immunoassays, which rely on antibodies to detect the protein. The newest versions of these tests can detect concentrations as low as 0.1 ng/mL, making them extremely sensitive. Their weakness, as noted above, is vulnerability to interference from thyroglobulin antibodies and other substances.
A newer approach uses mass spectrometry, which identifies thyroglobulin by measuring specific protein fragments rather than relying on antibody binding. This method largely sidesteps the antibody interference problem, making it valuable for the subset of patients whose antibodies render standard testing unreliable. The trade-off is sensitivity: mass spectrometry assays currently detect thyroglobulin down to about 0.4 to 0.5 ng/mL, which is less sensitive than the best immunoassays. For most patients without antibody interference, the standard immunoassay remains the preferred option.
How to Prepare for the Test
The test is a simple blood draw, and in most cases no special fasting is required. However, one important preparation step is often overlooked: if you take biotin supplements, you should stop them before your blood draw. Biotin (vitamin B7), commonly found in hair, skin, and nail supplements at doses of 5 to 10 mg, has been shown to interfere with thyroglobulin immunoassays, producing falsely low results. For thyroglobulin testing specifically, researchers recommend stopping biotin for more than 24 hours before the draw, which is longer than the 24-hour window sufficient for other thyroid tests. Let your doctor know if you take any supplements containing biotin so the timing can be adjusted.
Consistency across tests also matters. Because different lab platforms can produce slightly different thyroglobulin values, having your blood tested at the same lab each time makes it easier to track meaningful trends rather than chasing differences caused by switching methods.